{"title":"评估2019 - 2020年伊朗马什哈德伊玛目礼萨医院曲马多中毒患者癫痫发作发生率及其与血糖水平的关系","authors":"Seyed Reza Mousavi, Faezeh Jafari, Anahita Alizade Ghamsari, Mina AkbariRad, Majid Khadem-Rezaiyan, Seyed Amirhossein Mousavi, Sadaf Sadat Rafati","doi":"10.1155/jt/8335323","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> Drug poisoning is the most common type of poisoning in the world. The utilization of tramadol for the management of pain has been identified as a significant contributor to the incidence of poisoning cases. Tramadol poisoning can result in a range of neurological complications, including seizures and a decreased level of consciousness. Tramadol-induced seizures are frequently dose independent and manifest as generalized tonic-clonic seizures. The neurotoxic effects of tramadol are primarily manifested within the initial 24 h period following ingestion, with 84.6% of the seizures occurring within the first six hours. In addition, it has been documented that 15%-35% of the patients with tramadol poisoning have experienced seizures. The present study was undertaken to elucidate the clinical and paraclinical signs and symptoms observed in patients with tramadol poisoning and their correlation with the occurrence of seizures. <b>Methods and Materials:</b> All patients hospitalized due to tramadol poisoning from October 2019 to September 2020 in the poisoning department of Imam Reza Hospital if they met the inclusion criteria were studied. The patients were divided into two groups with and without seizures. The occurrence of seizures was substantiated through the documentation of EMS personnel and the direct observation of the attending physician in the emergency room. Following admission, the patient's blood glucose level was quantified via a glucometer. A blood sample was also obtained for subsequent laboratory evaluation. In the event of any aberrations in blood glucose levels, a re-evaluation was conducted at one-hour intervals using a glucometer. All findings were analyzed using SPSS Version 25 statistical software. The level of significance was set at <i>p</i> < 0.05. <b>Results:</b> A total of 163 patients were included in this study. In 94 patients (57.3%), some degree of consciousness loss and seizures occurred in 69 patients (42.1%). There was a significant relationship between the occurrence of seizures and the increase in blood glucose levels of patients (<i>p</i>=0.031). The findings indicated that 60% of the patients with blood glucose levels exceeding 140 mg/dL experienced seizures. <b>Conclusion:</b> Seizures in tramadol poisoning may be related to the patient's blood glucose levels.</p>","PeriodicalId":17421,"journal":{"name":"Journal of Toxicology","volume":"2025 ","pages":"8335323"},"PeriodicalIF":3.4000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11824836/pdf/","citationCount":"0","resultStr":"{\"title\":\"Evaluating the Incidence of Seizures and Its Relationship With Blood Glucose Levels in Tramadol Poisoning Patients Admitted to Imam Reza Hospital in Mashhad (Iran) From 2019 to 2020.\",\"authors\":\"Seyed Reza Mousavi, Faezeh Jafari, Anahita Alizade Ghamsari, Mina AkbariRad, Majid Khadem-Rezaiyan, Seyed Amirhossein Mousavi, Sadaf Sadat Rafati\",\"doi\":\"10.1155/jt/8335323\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Background:</b> Drug poisoning is the most common type of poisoning in the world. The utilization of tramadol for the management of pain has been identified as a significant contributor to the incidence of poisoning cases. Tramadol poisoning can result in a range of neurological complications, including seizures and a decreased level of consciousness. Tramadol-induced seizures are frequently dose independent and manifest as generalized tonic-clonic seizures. The neurotoxic effects of tramadol are primarily manifested within the initial 24 h period following ingestion, with 84.6% of the seizures occurring within the first six hours. In addition, it has been documented that 15%-35% of the patients with tramadol poisoning have experienced seizures. The present study was undertaken to elucidate the clinical and paraclinical signs and symptoms observed in patients with tramadol poisoning and their correlation with the occurrence of seizures. <b>Methods and Materials:</b> All patients hospitalized due to tramadol poisoning from October 2019 to September 2020 in the poisoning department of Imam Reza Hospital if they met the inclusion criteria were studied. The patients were divided into two groups with and without seizures. The occurrence of seizures was substantiated through the documentation of EMS personnel and the direct observation of the attending physician in the emergency room. Following admission, the patient's blood glucose level was quantified via a glucometer. A blood sample was also obtained for subsequent laboratory evaluation. In the event of any aberrations in blood glucose levels, a re-evaluation was conducted at one-hour intervals using a glucometer. All findings were analyzed using SPSS Version 25 statistical software. The level of significance was set at <i>p</i> < 0.05. <b>Results:</b> A total of 163 patients were included in this study. In 94 patients (57.3%), some degree of consciousness loss and seizures occurred in 69 patients (42.1%). There was a significant relationship between the occurrence of seizures and the increase in blood glucose levels of patients (<i>p</i>=0.031). The findings indicated that 60% of the patients with blood glucose levels exceeding 140 mg/dL experienced seizures. <b>Conclusion:</b> Seizures in tramadol poisoning may be related to the patient's blood glucose levels.</p>\",\"PeriodicalId\":17421,\"journal\":{\"name\":\"Journal of Toxicology\",\"volume\":\"2025 \",\"pages\":\"8335323\"},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2025-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11824836/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Toxicology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1155/jt/8335323\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"TOXICOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Toxicology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1155/jt/8335323","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"TOXICOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景:药物中毒是世界上最常见的中毒类型。曲马多用于疼痛管理已被确定为中毒病例发生率的重要贡献者。曲马多中毒可导致一系列神经系统并发症,包括癫痫发作和意识水平下降。曲马多诱发的癫痫发作通常与剂量无关,表现为全身性强直-阵挛性癫痫发作。曲马多的神经毒性作用主要表现在摄入后最初的24小时内,84.6%的癫痫发作发生在最初的6小时内。此外,有文献记载,曲马多中毒患者中有15%-35%出现癫痫发作。本研究旨在阐明曲马多中毒患者的临床和临床旁体征和症状及其与癫痫发作的关系。方法与材料:选取2019年10月至2020年9月伊玛目礼萨医院中毒科符合纳入标准的曲马多中毒住院患者。将患者分为有和无癫痫发作两组。通过EMS人员的记录和急诊室主治医生的直接观察,证实了癫痫发作的发生。入院后,通过血糖仪对患者的血糖水平进行量化。还获得了血液样本,以供随后的实验室评估。如果血糖水平出现异常,每隔一小时用血糖仪重新评估一次。所有结果采用SPSS Version 25统计软件进行分析。p < 0.05为显著性水平。结果:本研究共纳入163例患者。94例(57.3%)患者中,69例(42.1%)患者出现一定程度的意识丧失和癫痫发作。癫痫发作的发生与患者血糖水平升高有显著关系(p=0.031)。研究结果表明,60%的血糖水平超过140 mg/dL的患者出现癫痫发作。结论:曲马多中毒引起的癫痫发作可能与患者血糖水平有关。
Evaluating the Incidence of Seizures and Its Relationship With Blood Glucose Levels in Tramadol Poisoning Patients Admitted to Imam Reza Hospital in Mashhad (Iran) From 2019 to 2020.
Background: Drug poisoning is the most common type of poisoning in the world. The utilization of tramadol for the management of pain has been identified as a significant contributor to the incidence of poisoning cases. Tramadol poisoning can result in a range of neurological complications, including seizures and a decreased level of consciousness. Tramadol-induced seizures are frequently dose independent and manifest as generalized tonic-clonic seizures. The neurotoxic effects of tramadol are primarily manifested within the initial 24 h period following ingestion, with 84.6% of the seizures occurring within the first six hours. In addition, it has been documented that 15%-35% of the patients with tramadol poisoning have experienced seizures. The present study was undertaken to elucidate the clinical and paraclinical signs and symptoms observed in patients with tramadol poisoning and their correlation with the occurrence of seizures. Methods and Materials: All patients hospitalized due to tramadol poisoning from October 2019 to September 2020 in the poisoning department of Imam Reza Hospital if they met the inclusion criteria were studied. The patients were divided into two groups with and without seizures. The occurrence of seizures was substantiated through the documentation of EMS personnel and the direct observation of the attending physician in the emergency room. Following admission, the patient's blood glucose level was quantified via a glucometer. A blood sample was also obtained for subsequent laboratory evaluation. In the event of any aberrations in blood glucose levels, a re-evaluation was conducted at one-hour intervals using a glucometer. All findings were analyzed using SPSS Version 25 statistical software. The level of significance was set at p < 0.05. Results: A total of 163 patients were included in this study. In 94 patients (57.3%), some degree of consciousness loss and seizures occurred in 69 patients (42.1%). There was a significant relationship between the occurrence of seizures and the increase in blood glucose levels of patients (p=0.031). The findings indicated that 60% of the patients with blood glucose levels exceeding 140 mg/dL experienced seizures. Conclusion: Seizures in tramadol poisoning may be related to the patient's blood glucose levels.
期刊介绍:
Journal of Toxicology is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies in all areas of toxicological sciences. The journal will consider articles looking at the structure, function, and mechanism of agents that are toxic to humans and/or animals, as well as toxicological medicine, risk assessment, safety evaluation, and environmental health.